Statistics for Graves’ disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis
Total visits
| views | |
|---|---|
| Graves’ disease with spontaneous resolution following ocrelizumab in primary progressive multiple sclerosis | 367 |
Total visits per month
| views | |
|---|---|
| February 2025 | 0 |
| March 2025 | 0 |
| April 2025 | 0 |
| May 2025 | 0 |
| June 2025 | 0 |
| July 2025 | 0 |
| August 2025 | 0 |
File Visits
| views | |
|---|---|
| Duarte-2021-Graves-disease-with-spontaneous-res.pdf(legacy) | 15 |
| Duarte-2021-Graves-disease-with-spontaneous-res.pdf | 11 |
Top country views
| views | |
|---|---|
| China | 304 |
| United States | 23 |
| United Kingdom | 19 |
| Iran | 5 |
| Norway | 4 |
| Portugal | 3 |
| Japan | 2 |
| Ukraine | 2 |
| Australia | 1 |
| Belgium | 1 |
| Germany | 1 |
| France | 1 |